Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.

@article{Gore2012ClinicalCT,
  title={Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.},
  author={M. D. Richard M. Gore and K P Tai and Arthi Chandran and Gergana P Zlateva and Douglass L Leslie},
  journal={Journal of medical economics},
  year={2012},
  volume={15 1},
  pages={19-31}
}
OBJECTIVE To assess comorbidities, pain-related pharmacotherapy, and healthcare resource use among patients with fibromyalgia (FM) newly prescribed pregabalin or duloxetine (index event) in usual care settings. METHODS Using the LifeLink™ Health Plan Claims Database, patients with FM (International Classification of Diseases, Ninth Revision, Clinical Modification code 729.1X) were identified. Patients initiated on duloxetine were propensity score-matched with patients initiated on pregabalin… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Comparison of dosing patterns between fibromyalgia patients with high versus low duloxetine or pregabalin compliance

  • Y Zhao, P Sun, S Sun
  • Pain Pract
  • 2012

Similar Papers

Loading similar papers…